Fractyl Health Strengthens Revita Patent Portfolio
Fractyl Health reported patent milestones for Revita as it advances toward FDA submission and potential commercialization. The milestones build on positive six-month REMAIN-1 pivotal results and patient research support.
Story updates
11:05:04 AM UTC
SquawkNews
Fractyl Health added a U.S. patent for Revita’s catheter and received allowance for thermal dosing claims, complementing existing method and console patents, as it plans a De Novo FDA submission for post-GLP-1 weight maintenance.Material DetailsContext by AI AnalystThis is an IP and regulatory-prep…